Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc-dependent enzyme systems are a large and functionally diverse group of enzymes that rely on zinc ions for catalytic activity or structural integrity. Zinc acts either as a catalytic cofactor, facilitating chemical reactions, or as a structural element, stabilizing protein domains such as zinc finger motifs. Examples include carbonic anhydrase, alcohol dehydrogenase, metalloproteinases, alkaline phosphatases, and cytosine deaminase. Zinc-dependent enzymes participate in core biological processes, including metabolism, DNA synthesis, signal transduction, and gene expression regulation. Dysfunction or abnormal regulation of these enzymes is implicated in various diseases, such as cancer, neurodegenerative and cardiovascular diseases, and infections. Since this term denotes a class rather than a unique molecular entity, it is not a direct therapeutic target but rather a category encompassing many clinically relevant targets[4][5][7][8].
Enzyme inhibition (many drugs act as inhibitors of specific zinc-dependent enzymes, e.g., ACE inhibitors, matrix metalloproteinase inhibitors)[8] Metal chelation (some drugs act by chelating zinc and inhibiting enzyme activity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-dependent enzyme systems.